# the Use of Fosfomycin as a Single Dose Oral Treatment of Asymptomatic Bacteriuria

> **NCT03548129** · PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 88 (actual)

## Conditions studied

- Urinary Tract Infection

## Interventions

- **DRUG:** phosphomycin
- **DRUG:** Culture specific antibiotic therapy
- **DIAGNOSTIC_TEST:** Pre-treatment Urine Culture
- **DIAGNOSTIC_TEST:** Antimicrobial sensitivity testing
- **DIAGNOSTIC_TEST:** Post-treatment urine culture

## Key facts

- **NCT ID:** NCT03548129
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2018-07
- **Final completion:** 2018-08
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2018-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03548129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03548129, "the Use of Fosfomycin as a Single Dose Oral Treatment of Asymptomatic Bacteriuria". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03548129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*